US Patent Number
9,968,574
Publication Date
5-15-2018
Abstract
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
Assignees
The University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
12/949,724
Filing Date
11/18/2010
Recommended Citation
Lovell, Mark A. and Lynn, Bert C., "Treatment of MCI and Alzheimer's Disease" (2018). Chemistry Faculty Patents. 37.
https://uknowledge.uky.edu/chemistry_patents/37
Included in
Chemicals and Drugs Commons, Chemistry Commons, Diseases Commons, Neuroscience and Neurobiology Commons
